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Abstract
Background: Bifidobacteria are among the first anaerobic bacteria colonizing the gut. Bifidobacteria require iron for
growth and their iron-sequestration mechanisms are important for their fitness and possibly inhibit enteropathogens.
Here we used combined genomic and proteomic analyses to characterize adaptations to low iron conditions of
B. kashiwanohense PV20-2 and B. pseudolongum PV8-2, 2 strains isolated from the feces of iron-deficient African infants
and selected for their high iron-sequestering ability.
Results: Analyses of the genome contents revealed evolutionary adaptation to low iron conditions. A ferric and a
ferrous iron operon encoding binding proteins and transporters were found in both strains. Remarkably, the ferric iron
operon of B. pseudolongum PV8-2 is not found in other B. pseudolongum strains and likely acquired via horizontal
gene transfer. The genome B. kashiwanohense PV20-2 harbors a unique region encoding genes putatively involved in
siderophore production.
Additionally, the secretomes of the two strains grown under low-iron conditions were analyzed using a combined
genomic-proteomic approach. A ferric iron transporter was found in the secretome of B. pseudolongum PV8-2,
while ferrous binding proteins were detected in the secretome of B. kashiwanohense PV20-2, suggesting different
strategies to take up iron in the strains. In addition, proteins such as elongation factors, a glyceraldehyde-3-phosphate
dehydrogenase, and the stress proteins GroEL and DnaK were identified in both secretomes. These proteins have been
previously associated with adhesion of lactobacilli to epithelial cells.
Conclusion: Analyses of the genome and secretome of B. kashiwanohense PV20-2 and B. pseudolongum PV8-2
revealed different adaptations to low iron conditions and identified extracellular proteins for iron transport. The
identified extracellular proteins might be involved in competition for iron in the gastrointestinal tract.
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Background
Iron is an essential micronutrient for most organisms
and is taken up by high affinity transport systems [1].
Two oxidized forms of iron, ferric (Fe3+) and ferrous
iron (Fe2+), occur in nature with ferrous iron being to be
most abundant in the intestine [2]. Iron is limited in
most environments and a battle for iron occurs in many
microbial ecosystems, including the human gastro-
intestinal (GI) tract [3, 4]. Withholding iron is therefore
a competitive and defense trait in many Gram-positive
and Gram-negative bacteria [5, 6]. Predominant mem-
bers of an ecosystem frequently possess efficient iron-
scavenging systems which enable them to outcompete
other microorganisms by depriving them from iron [7]. In
addition, restricting iron to pathogens in the GI-tract has
been coined as nutritional immunity phenomenon and is
usually associated with efficient iron-sequestration systems.
Bifidobacteria are non-sporeforming, nonmotile, an-
aerobic, Gram-positive bacteria with a high G + C con-
tent that are residents of the GI-tract and predominant
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in infants [8]. Bifidobacteria have been shown to benefi-
cially modulate the composition and activity of the intes-
tinal microbiota, to prevent bacterial infections, and to
exert anti-inflammatory and immunomodulation activ-
ities [9]. These beneficial traits depend strongly on the
ability of a strain to survive and to adapt in the GI-tract
[10]. Adaptation and survival involve the use of efficient
and diverse nutrient uptake systems, enzymes, stress
proteins, and factors that interact with the host and with
other members of the gut microbiota [11].
Bifidobacteria require iron for growth and produce
extracellular binding proteins that are involved in iron
uptake [12]. Such iron-binding proteins may also be
implicated in iron withholding thereby limiting the avail-
ability to pathogens in the GI-tract [13]. Additionally,
the essential micronutrient zinc might have a similar
role in ecosystems as iron, and mechanisms for zinc
sequestration have been recently reported to further
contribute to nutritional immunity by similar mecha-
nisms as iron sequestration [14–16].
Bacterial extracellular proteins are either actively
transported through the cytoplasmic membrane into the
environment or simply shed from the surface. The com-
position of the extracellular proteome, also known as the
secretome, strongly depends on the nutrient preferences
of the bacterium [17]. Bifidobacterial secretomes have
been used to study diversity and physiology of the genus,
and to identify differences in nutrient uptake and stress
response [18, 19]. Extracellular proteins of bifidobacteria
are pivotal for host interactions and -adaptations, for
nutrient uptake, adhesion, and stress sensing [20–24].
Further, extracellular proteins of bifidobacteria are
potentially directly involved in mechanisms beneficial to
the host [25], and the secretome is therefore an ideal
target to understand interactions and responses of
bifidobacteria in the GI-tract.
Functional genomics is powerful to identify bifidobac-
terial mechanisms active in the gut, such as genes
involved in host-microbe interactions, the degradation of
human milk oligosaccharides, or pili encoding genes
[10, 23]. Combined genomic and proteomic analyses of
bifidobacteria revealed mechanisms of adaptation to the
GI-tract and genetic functions that mediate specific host-
microbe and microbe-microbe interactions [26, 27]. In
contracts to genomics, proteomic detects the functional
gene products that are present under specific conditions
[28, 29]. Proteomic also allows comparison of strain spe-
cific features under similar conditions and is therefore well
suited for studying features which may not be accessed by
genomics [28]. However, analyses of proteomic mass spec-
tra (MS) rely upon homology with pre-established protein
sequences derived from genus related databases [30]. Such
approach will inevitably fail to identify strain-unique pro-
tein sequences [22] and because many bifidobacterial
properties are strain specific, homology-driven proteomics
has limits to identify important phenotypic features [19].
A combined genomic-proteomic approach in which the
genome is sequenced and used to build a protein database
is therefore more suitable for the analyses of the prote-
omic MS data form bifidobacteria.
Bifidobacterium kashiwanohense PV20–2 and Bifido-
bacterium pseudolongum PV8–2 were isolated from the
feces of breast-fed, anemic Kenyan infants. These strains
exhibit high iron sequestration mechanisms and their
whole genomes have been sequenced [12, 31, 32]. In this
study, the genomes of B. kashiwanohense PV20–2 and B.
pseudolongum PV8–2 were compared to other bifido-
bacterial genomes to identify genes potentially involved
in iron metabolism. Further, we identified the secretome
of both strains under iron limiting conditions using a
combined genomic-proteomic approach. In this ap-
proach, the predicted coding sequences were used to
identify MS/MS-peptides obtained via a 1D gel-based
shotgun proteomic approach.
Results
Comparative genome analyses of B. kashiwanohense
PV20–2
B. kashiwanohense PV20–2 (PV20–2) and B. pseudolongum
PV8–2 (PV8–2) were selected for their high iron sequestra-
tion in a screening of 56 bifidobacterial strains isolated
from the feces of anemic infants in Kenya [12]. To analyze
whether specific adaptations related to iron uptake were
present in the genomes, we compared the complete ge-
nomes of PV20–2 and PV8–2 to 82 completely or par-
tially sequenced bifidobacterial genomes (Additional file 1:
Table S1).
The genome of PV20–2 contains 2077 CDSs. A compari-
son to 82 bifidobacterial genomes, including that of B.
kashiwanohense strain DSM 21854, revealed 58 CDSs
unique for PV20–2, of which 55 encode hypothetical func-
tions (Additional file 2: Table S2). Interestingly, the two
unique CDSs AH68_05490 and AH68_05500 are located in
a region containing genes that are not or rarely found in
other bifidobacteria (region AH68_05460–05520). Refined
analyses of the genes in this region revealed that they have
high homology to non-ribosomal peptide synthesis genes.
Moreover, a conserved domain search [33] shows that the
protein encoded by AH68_05485 contains a non-ribosomal
peptide synthesis domain (e-score = 9.28e-127). This pro-
tein has only one poor hit in the genome comparison, in
Bifidobacterium adolescentis L2-32 (e-score = 3.14e-14).
The 560 AA at the C-terminus of this CDS share 33%
identity and 52% similarity with a bacillibactin synthe-
tase from Bacillus subtilis 168 [34], and 26% identity
and 48% similarity with a pyoverdine synthetase from
Pseudomonas aeruginosa [35], both enzymes involved
in siderophore biosynthesis. Upstream of the putative
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siderophore synthesis genes an ABC-transporter is
located (AH68_05505).
Additionally, PV20-2 was compared solely to the type
strain B. kashiwanohense DSM 21854 [23]. PV20-2 con-
tained 252 proteins not found in DSM 21854. Of these
proteins, 197 were found in one or more of the 82 bifi-
dobacterial genomes used in this study (Additional file 1:
Table S1 and Additional file 2: S2). Of these 197 CDSs,
47 had highest homology to proteins in B. longum strains,
followed by Bifidobacterium adolescentis (32 CDSs), Bifi-
dobacterium pseudocatenulatum (24) and Bifidobacterium
breve (22). Finally, PV20–2 contained a ferrous and a fer-
ric operon (Fig. 1), both also present in strain DSM 21854.
Comparative genome analyses of B. pseudolongum PV8–2
In parallel, B. pseudolongum PV8–2 was compared to
the 82 bifidobacterial genomes and separately to the two
available genomes of the species; B. pseudolongum AGR
2145 (fecal calf isolate) and B. pseudolongum subsp.
globosum DSMZ 20092 (rumen isolate). The genome of
PV8–2 harbored 1552 protein encoding genes of which
22 were not found in any other bifidobacterial genomes
(Additional file 3: Table S3). The products of these 22
CDS encoded hypothetical or phage related functions. A
total 78 CDSs did not have homologs in the two B. pseu-
dolongum strains, of which 56 were found in other bifi-
dobacterial genomes (Additional file 3: Table S3). Two
larger insertions were found in the PV8–2 genome. One
insertion encodes genes for arabinogalactan transport
and utilization (AH67_01080–01120) that are organized
in a similar order as in B. adolescentis ATCC 15703
(data not shown). In addition, two galactosidases
(AH67_0181 and AH67_1596) were identified in PV-8–2
and not in the other B. pseudolongum strains, which
might be involved in degradation of the galactose moiety
of arabinogalactan. A second insertion contains an iron
ABC transporter operon consisting of a ferric iron bind-
ing protein (AH67_02660), two membrane components
(AH67_02665 and 02670), and the ATP-binding protein
(AH67_02675). Detailed comparison of the correspond-
ing genome regions of the three B. pseudolongum strains
showed a highly conserved organization, with exception
of the iron operon (Fig. 2), strongly suggesting that the
operon has been acquired by PV8–2. The GC -content
of the insertion is 59.4%, only slightly lower than that of
the genome (62.4%). The encoded proteins were found
only in an unknown faecal isolate belonging to the Acti-
nobacteria phylum and in the rumen isolate Bifidobac-
terium sp. AGR2156 (cut off 80% similarity).
Besides the ferric iron operon described above, also a
ferrous iron transporter was predicted in PV8–2
(AH67_05680, Fig. 1). This transporter is also found in
the other two B. pseudolongum strains and a BLAST
search revealed that it is present in many bifidobacteria
(data not shown).
Secretome analysis of B. kashiwanohense PV20–2 and
B. pseudolongum PV8–2 under low iron conditions
The iron uptake mechanisms of PV20–2 and PV8–2
were further studied by secretome analyses during
growth under low iron conditions. The strains were
grown in a chemically semi-defined medium with a low
iron concentration of 1.5 μM [12] and extracellular pro-
teins were isolated and identified by LC/MS. A total of
112 proteins were identified in the secretome of PV20-2
(Additional file 4: Table S4) of which 34 (30%) were pre-
dicted to contain a classical signal peptide, 46 (41%)
were predicted to be secreted by a non-classical
Fig. 1 Ferric and ferrous operons identified in the genome of B. kashiwanohense PV20-2 (AH_68) and B. pseudolongum PV8-2 (AH_67). Homologous
genes are indicated by the same colors
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secretion pathways, and 32 (29%) were previously re-
ported to be extracellular (Fig. 3). In PV8–2, 92 proteins
were identified in the exoproteome (Additional file 4:
Table S5). Of these, 28 (30%) were predicted to contain a
classical signal peptide, 34 (36%) were predicted to be se-
creted by a non-classical secretion pathway and 30 (33%)
were previously reported to be extracellular (Fig. 3). Of
the 112 identified proteins in PV20–2, 66 proteins had a
homologue in the secretome of PV8–2 (Table 1).
Remarkably, the secretome of PV8–2 contained a fer-
ric - iron transporter (AH67_02660) but no ferric trans-
porter was detected. In contrast, secretome of PV20–2
contained three ferrous iron transporters AH68_00590,
AH68_00595 and AH68_00600. In addition, the ABC-
transporter genetically linked to the putative siderophore
genes (AH68_05505) was found. Among the proteins
identified in both secretomes were 3 elongation factors,
a glyceraldehyde-3-phosphate dehydrogenase, proteins
related to stress and transporters, including the zinc ABC
transporter ZnuA (Table 1). A second protein with zinc
binding function (ZinT, locus tag AH67_08575) was iden-
tified in PV8–2 secretome (Additional file 4: Table S5).
Further, some clear surface related proteins were identified
such as a penicillin binding protein and a membrane pro-
tein. In the exoproteome of PV8–2 a lysozyme M1
(AH67_08110) was identified.
Discussion
In this study we analyzed two bifidobacteria strains that
had the highest iron sequestration capacity among 56
bifidobacterial isolates from stools of iron - deficient
Kenyan infants [12]. Using a comparative genomics and
a combined proteomic-genomic approach we identified
in both strains specific adaptations to the low iron con-
centration encountered in the GI-tract of iron-deficient
infants.
The comparative genome analyses revealed adapta-
tions to low iron conditions and to a specific diet, thus
the genomic content reflects the source of the strains, as
already proposed previously for bifidobacteria [36]. B.
kashiwanohense PV20–2 encodes genes putatively in-
volved in bacillibactin and pyoverdines syntheses that
were not present in strain DSM 21854. Bacillibactins
and pyoverdines are both siderophores [34, 35] and the
corresponding genes in PV20–2 could encode for the syn-
thesis of a bifidobacterial siderophore. The identification
Fig. 2 Genetic organization of the ferric operon of B. pseudolongum PV8-2 and comparison of the region to B. pseudolongum AGR2145. Homologous
genes are linked with red lines and their degree of identity provide as percentage of identity. The inserted genes in B. pseudolongum PV8-2 are
indicated in white: I: Ferric iron ABC transporter, iron-binding, II: IRON(III)-Transport system permease protein, III: Thiamin ABC transporter, transmembrane,
IV: Ferric iron ABC transporter, ATP-binding protein, V: COG family: predicted phosphohydrolases
Fig. 3 Distribution of proteins in the secretome of PV20-2 (B. kashiwanohense PV20-2) and PV8-2 (B. pseudolongum PV8-2). Colored circles show
the fraction of proteins secreted by classical secretion pathway (blue), non-classical secretion pathway (red) and identified in literature (green). Right
circle, represent the percentage of proteins identified in PV8-2 secreted classical secretion pathway (N-terminal sequence, blue), non-classical secretion
pathway (N-terminal sequence, red) and the ones identified in literature (green)
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Table 1 Proteins identified in the exoproteome of B. kashiwanohense PV20-2 with an homologue in B. pseudolongum PV8-2
Locus tag Assigned function Homologue in PV8-2 SPa Secretedb
AH68_05990 membrane protein AH67_04310 x
AH68_00170 serine/threonine protein kinase AH67_00415 x
AH68_00180 penicillin-binding protein AH67_00425 x x
AH68_00315 peptidase AH67_00490 x
AH68_00635 membrane protein AH67_00835 x
AH68_00655 peptidase C69 AH67_00865 x
AH68_00900 penicillin-binding protein AH67_01125 x
AH68_00945 phosphotransferase AH67_01155
AH68_01075 glycerol-3-phosphate acyltransferase AH67_01265
AH68_01345 glucose-6-phosphate isomerase AH67_01530
AH68_01575 phosphate ABC transporter substrate-binding protein AH67_01870 x x
AH68_01610 50S ribosomal protein L7 AH67_01905
AH68_01655 molecular chaperone GroES AH67_01950
AH68_01785 50S ribosomal protein L4 AH67_02085
AH68_01885 adenylate kinase AH67_02185
AH68_02020 hypothetical protein AH67_02295 x x
AH68_02050 PTS mannose transporter subunit IIABC AH67_02320 x
AH68_02165 amidase AH67_02505 x
AH68_02170 peptidase P60 AH67_02510 x x
AH68_02465 branched-chain amino acid ABC transporter
substrate-binding protein
AH67_02445 x x
AH68_02570 amidase AH67_03020 x x
AH68_02580 ABC transporter substrate-binding protein AH67_03110 x x
AH68_02785 amino acid ABC transporter substrate-binding protein AH67_06815 x x
AH68_02795 methionine ABC transporter ATPase AH67_06850 x x
AH68_02900 arylsulfatase AH67_03300 x
AH68_03085 elongation factor G AH67_03425
AH68_03090 elongation factor Tu AH67_03430
AH68_03095 elongation factor P AH67_03450 x
AH68_03260 molecular chaperone GroEL AH67_03615
AH68_03390 ABC transporter substrate-binding protein AH67_03690 x
AH68_03430 Clp protease AH67_05875
AH68_03845 hypothetical protein AH67_05645 x
AH68_03865 enolase AH67_05625
AH68_03915 transcription elongation factor GreA AH67_05585
AH68_03955 transcriptional regulator AH67_05555 x x
AH68_03970 hypothetical protein AH67_05545 x x
AH68_04025 ABC transporter substrate-binding protein AH67_05490 x x
AH68_04165 acetate kinase AH67_05125
AH68_04240 hypothetical protein AH67_05000 x
AH68_04280 hypothetical protein AH67_04940 x
AH68_04600 ABC transporter substrate-binding protein AH67_00280 x x
AH68_05530 choloylglycine hydrolase AH67_04680 x
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in the secretome of an ABC-transporter genetically linked
to the putative siderophore genes suggest that this trans-
porter is involved in the uptake of the iron-siderophore
complex. In the B. pseudolongum PV8–2 strain, iron re-
lated genome content included a ferric iron transporter
clearly inserted in the genome (Fig. 2). The GC-content of
59.4% of the insertion suggests it has been acquired from
a high-GC-content bacterium. It is, however, not known
when the insertion occurred and it is therefore also pos-
sible that the sequence is already adapted to the host
chromosome for its GC-content. The origin of this inser-
tion is therefore not clear. The presence of a siderophore
operon in strain PV20–2 and an additional iron trans-
porter in PV8–2 seems directly related to the selective
pressure mediated by the low-iron abundance in the gut
of the iron-deficient infants.
Arabinogalactan are pectin derived sugars that can be
utilized by some bifidobacteria [37] and the correspond-
ing genes have been described in B. breve [38]. Arabino-
galactan is found in plant cell wall and is a potential
prebiotic with some selectivity for bifidobacteria [39]
The occurrence of an arabinogalactan machinery in the
human isolate PV8–2, and not in the rumen isolates
DSM 20092 and AGR 2145 might be related to the spe-
cific diet of the Kenyan infant from whom feces the strain
was isolated. The infant weaning diet is composed of
mother’s milk and maize porridge cooked in water, and
therefore containing arabinogalactan-rich source [40].
Approximately 75% of the CDSs that were unique for
PV8–2 and PV20–2 in the direct comparison to strains of
their own species were found in other bifidobacteria. This
suggests that the corresponding genes have been acquired
from other bifidobacteria and that horizontal gene transfer
(HGT) occurs between members of the phylum. In
addition, the ferric iron operon of PV20–2 is inserted in a
conserved genome region and likely acquired via HGT.
The high cell densities and strong selective pressure in the
GI-tract facilitate HGT and outgrowth of novel variants
[41, 42]. In addition, costs of gene transfer are lower if the
genes fit well in the recipient’s system and transfer occurs
therefore easier between related species [43]. The occur-
rence of a whole set of genes horizontal through the genus
Table 1 Proteins identified in the exoproteome of B. kashiwanohense PV20-2 with an homologue in B. pseudolongum PV8-2
(Continued)
AH68_05760 transaldolase AH67_04590
AH68_05765 transketolase AH67_04585
AH68_06400 glutamine synthetase AH67_03825
AH68_06950 peptidylprolyl isomerase AH67_05945
AH68_07210 ABC transporter substrate-binding protein AH67_06260 x x
AH68_07300 glyceraldehyde-3-phosphate dehydrogenase AH67_06350
AH68_07370 peptide ABC transporter substrate-binding protein AH67_06260 x x
AH68_07705 Lon protease AH67_06760 x
AH68_08215 hypothetical protein AH67_07275 x
AH68_08365 glycine cleavage system protein H AH67_07395
AH68_08385 thioredoxin AH67_07415
AH68_08390 hypothetical protein AH67_07420 x
AH68_08925 hypothetical protein AH67_07735 x x
AH68_08940 peptidylprolyl isomerase AH67_07745 x x
AH68_08975 ATP synthase F0F1 subunit B AH67_07780 x
AH68_09035 inorganic pyrophosphatase AH67_07840
AH68_09070 hypothetical protein AH67_07875 x
AH68_09115 glutamyl-tRNA amidotransferase AH67_07920
AH68_09245 single-stranded DNA-binding protein AH67_08040 x
AH68_09250 30S ribosomal protein S6 AH67_08045
AH68_09340 phosphoglycerol transferase AH67_08095 x
AH68_09765 heat shock protein GrpE AH67_08330 x
AH68_09770 molecular chaperone DnaK AH67_08335 x
AH68_10135 sugar ABC transporter ATP-binding protein AH67_08590
a signal peptide predicted according to [22]
bas predicted by SecretomeP 2.0
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strongly suggests that HGT events occur frequently be-
tween bifidobacteria. The unique genes of PV20–2 and
PV8–2 encoded mostly hypothetical or phage related func-
tions, paralleling an observation in the B. breve taxon [44].
Bacteria, including bifidobacteria, secrete proteins to
ensure the acquisition of essential nutrients, cell to cell
communication, and competition in their respective
niches [45]. Extracellular proteins related to iron metab-
olism, adhesion and antimicrobial activity were identified
in the secretome of PV8–2 and PV20–2. Both strains ap-
parently use therefore a combination of strategies to effi-
ciently compete and interact with the environment. This
observation is in agreement with recent observations
that several mechanisms are used by bacteria to compete
in different environments [46–49]. Furthermore, the abil-
ity of bacteria to occupy specific environments mainly re-
lies on their ability to obtain adequate supplies of
nutrients that are indispensable for their growth, such as
iron [50, 51]. In the exoproteome of B. kashiwanohense
PV20–2 three ferrous iron transporters were identified
which seems directly related to the high iron internaliza-
tion activity of the strain [12]. In contrast, in the exopro-
teome of PV8–2 a ferric iron transporter was identified.
This suggests different iron acquisition strategies in both
strains. Remarkably, the ferric transporter of PV8–2 is
likely acquired via HGT and its occurrence in the secre-
tome shows that it is active. The absence of ferrous trans-
porter proteins in the secretome suggests that the
acquired ferric transporter has taken over the function for
iron uptake. The competition for iron within the gut
microbiota and the limited availability of iron in the intes-
tine, leads to a constant battle for iron between the enteric
microbiota and the host [7, 52, 53]. Thus efficient iron ac-
quisition mechanisms are likely pivotal for proliferation
and persistence in the gut [14, 16, 54]. Production of iron
binding proteins by bifidobacteria may also limit the iron
available for pathogens thus potentially being implicated
in a so called nutritional immunity phenomenon [55–57].
In competition, inhibition, and displacement assays using
HT29-MTX cell lines, strain PV8–2 reduces adhesion of
Salmonella Typhimurium and Escherichia coli O157:H45
while strain PV20–2 only reduced adhesion of S. Typhi-
murium [58]. This competitive strength of especially
PV8–2 might be in part due to iron binding mechanism
limiting iron availability for pathogens.
The zinc ABC transporter ZnuA was identified in the
exoproteome of both strains. Zinc metal transporters may
facilitate, although to a lesser extent, the uptake of other di-
valent ions, such as iron [59]. Alternatively, their detection
may be the result of a common micronutrient stress sens-
ing. Further, ZinT was identified in PV8–2. ZinT forms a
complex with ZnuA to enhance its activity. ZinT was iden-
tified in the extracellular fraction of enterohemorrhagic E.
coli where it was important for colonization [60, 61]. Zinc
competition in the intestine may also play a role in nutri-
tional immunity and control of enteropathogens growth,
but further research is needed to confirm the beneficial ef-
fects of zinc sequestration in the gut environment [14, 47].
Elongation factors have been found in the secretome
lactobacilli and are involved in the adhesion Lactobacillus
johnsonii to human intestinal cells and mucins [62, 63].
Their presence in the secretome and the high adhesion
properties of both strains [64] suggests a similar role for
these factors in bifidobacteria. Similarly, glyceraldehyde-3-
phosphate dehydrogenases, and the stress proteins GroEL
and DnaK were previously shown to be involved in
adhesion of lactobacilli [65–68], and their occurrence in
the secretome of PV20–2 and PV8–2 suggests same
functionality.
The vast majority of the proteins identified in both
secretomes possess an N-terminal signal peptide, and are
predicted to be secreted, or were already shown to be
extracellular (Additional file 4: Table S4 and S5). In
addition, many proteins were predicted to be lipoproteins,
while lipoproteins of bifidobacteria were reported to
stimulate the immune system and were involved in adhe-
sion [69, 70]. However, the implication of these proteins in
more than one function has to be further tested. Further-
more, the lysozyme M1 might be involved in inhibition
against competing microorganisms. Lysozymes or glyco-
side hydrolases such as N-acetylmuramidases are reported
to be involved in competition and antimicrobial activity
because they can act as bacteriolysins [71].
Conclusions
In our study we used genomics and proteomics to
characterize the response to low iron conditions of B. kashi-
wanohense PV20-2 and B. pseudolongum PV8–2, selected
for their high iron sequestration properties. The expression
of ferric and ferrous binding proteins and the different re-
sponses to iron limitation reflect strain specific characteris-
tics, which is in agreement with high strain variation
among bifidobacteria. In addition, to the ferrous iron
operon identified in the genome of both studied strains,
PV8-2 was shown to have a specific ferric iron operon. The
iron binding proteins identified in this study are likely in-
volved in iron metabolism. By combining functional assays
and genomics and proteomic tools we could uncover iron-
sequestration mechanisms that could provide important
competition edge for colonization in the low iron environ-
ment of the infant gut. However, the specific function of
the extracellular proteins disclosed in this study and their
role in the GI-tract colonization remain to be investigated.
Methods
Strains and growth conditions
B. kashiwanohense PV20-2 and B. pseudolongum PV8-2
were previously isolated from stool samples of iron
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deficient Kenyan infants [12]. Pre-cultures were per-
formed in MRS broth (Biolife, Italy), supplemented with
0.5 g/L L-cysteine (Sigma-Aldrich, Switzerland), anaer-
obically at 37 °C in Hungate tubes with CO2 headspace
(PanGas, Switzerland). Growth was monitored in a Bio-
wave CO8000 spectrophotometer (Biochrom England).
Pre-cultures with an OD600 of 1.5 were centrifuged and
cells were suspended in peptone water (Oxoid,
Switzerland) supplemented with 0.05% L-cystein, pH 6.5.
A portion of 3.75 mL of this suspension was used to in-
oculate 250 mL of a chemically semi-defined medium with
an iron concentration of 1.5 μM described previously [12].
The iron concentration in the media was measured using
a graphite furnace atomic absorption spectrophotometer
(AA-240Z, Varian Inc., Australia) according to manufac-
turer’s instructions [72]. Cultures were incubated at 37 °C
under anaerobic conditions until an OD600nm 1.5 (corre-
sponding to the early stationary phase). Three biological
replicates were performed.
Analyses of the genomes of B. kashiwanohense PV20-2
and B. pseudolongum PV8-2
The genomes of B. kashiwanohense PV20–2 (Genbank
accession number CP007456), and B. pseudolongum
PV8–2 (CP007457) were compared to a local database
containing the genomes of 42 completely sequenced and
40 draft genomes of bifidobacteria (Additional file 1:
Table S1), using the tBLASTn algorithm [73] embedded in
the CLC genomic workbench 7.0 (CLC genomics,
Denmark). The E-value cut off was set at < 1exp-4, as was
used previously for comparative genomics of bifidobacteria
[74]. Comparisons of genetic organization were visualized
by the Artemis Comparison viewer [75] with input files
that were produced using Double Act version 2 (http://
www.hpa-bioinfotools.org.uk/pise/double_act.html).
Coding sequences (CDS) were predicted from the gen-
ome and signal peptides were identified using SignalP
4.1 (http://www.cbs.dtu.dk/services/SignalP, [22]) with
the option “Gram-Positive” bacteria as organism group,
default D-cutoff values (0.45) and transmembrane re-
gions included. Non-classical protein secretion was pre-
dicted with SecretomeP 2.0 (http://www.cbs.dtu.dk/
services/SecretomeP, [76]) with Gram-positive bacteria
selected as organism group. A protein with signal pep-
tide was considered when the SecP score was above 0.5.
Lipoproteins were identified using PredLipo with default
parameters [77].
Extraction of extracellular proteins and 1D gel
electrophoresis
Cultures were centrifuged at 10,000 × g at 4 °C for
10 min and the supernatants were passed through a
0.22 μm pore size filter (Millipore, Switzerland). Proteins
in the supernatant were precipitated with 10% v/v
trichloroacetic acid (Sigma-Aldrich) at 4 °C for 3 h and
harvested by centrifugation at 11,000 × g at 4 °C for
30 min. The precipitate was washed twice with ice-cold
acetone, dried in a centrifugal vacuum concentrator
(Vacufuge 5301, Eppendorf, Switzerland), and stored at
−20 °C until further use. Protein pellets were solubilized
in 250 μL of 50 mM ammonium bicarbonate at pH 8.5
(AmBic). Protein concentrations were determined ac-
cording to Bradford using Bradford reagent (Sigma
Aldrich) and bovine serum albumin as standard.
Tricine sodium-dodecyl sulfate polyacrylamide gel elec-
trophoresis was used to separate the proteins [78]. The
precipitated proteins were mixed 1:1 with Tricine
Laemmli sample buffer (Biorad, Switzerland), as described
by manufacturer’s instructions, and incubated for 7 min at
99 °C in a Dri-Block (Witec, Switzerland). 50 μg of
standardized protein mixture was loaded on a 10–20%
Tris-Tricine Mini-Protean TGX precast gel (Biorad), with
tris-tricine as running buffer (Biorad, Switzerland). The
gel was run at 180 V for 40 min, stained with Coomassie
blue G250 and destained with 10% (v/v) acetic acid
(Sigma-Aldrich). Gel lanes were cut in eight fractions and
prepared for mass spectrometry analysis as described pre-
viously [79], with slight modifications. Briefly, gel fractions
were washed twice with 50 mM AmBic / 5% acetonitrile
(ACN) and dehydrated using 100% ACN. Subsequently,
gel pieces were treated with sequencing grade trypsin
(Promega, Switzerland) for 1 h at 4 °C according to manu-
facturer’s instructions. Thereafter, 50 μl digestion buffer
containing 50 mM AmBic, pH 8.5 was added, followed by
incubation at 37 °C for 16 h. The generated tryptic pep-
tides were extracted with 0.1% trifluoroacetic acid/50%
ACN v/v at 37 °C in an ultrasonicator (VWR, Switzerland)
for 15 min and finally concentrated with a vacuum
concentrator. Peptides were desalted using ZipTip C18
micro-columns (Millipore, Switzerland) following the
manufacturer’s instructions, and finally dried in a vacuum
concentrator. The dried peptide mixture was suspended
in 5% ACN/0.1% formic acid v/v for LC-MS/MS
measurements.
Acquisition of proteome data
All data were acquired on an LTQ OrbitrapVelos mass
spectrometer connected with an Easy-nLC 1000 HPLC
system (Thermo Fisher Scientific, Germany). Peptide
samples (4 μL) were loaded onto a frit column (75 μm
inner diameter) packed with reverse phase C18 material
AQ with 3 μm particle size and 200 Å pore size (Bischoff
GmbH, Leonberg, Germany), and eluted with a flow rate
of 300 nL per min. Solvent composition of buffer A was
0.1% formic acid in water, and buffer B contained 0.1%
formic acid in acetonitrile. The following liquid chroma-
tography gradient was applied: 0 min: 0% buffer B,
90 min: 30% B, 92 min: 100% B, 100 min: 100% B.
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Survey scans were recorded in the Orbitrap mass
analyzer in the range of m/z 300–2000, with a resolution
of 30000 at m/z 400. Collision-induced dissociation
(CID) spectra were acquired in the ion trap, from the 20
most intense signals above a threshold of 1000 counts. A
normalized collision energy of 35% and an activation
time of 10 ms were used for CID. The precursor ion iso-
lation width was set to m/z 2.0. Charge state screening
was enabled, and single charged ions and unassigned
charge states were rejected. Precursor masses already se-
lected for MS/MS acquisition were excluded for further
selection during 45 s, and the exclusion window was
20 ppm.
Protein identification
Peak lists were generated with Mascot Distiller 2.4.1 from
Matrix Science using the Thermo MSFile Reader 2.2. Mas-
cot Daemon 2.4 was used for merging and submitting
the.mgf files from Xcalibur FT package 2.0.7. The resulting
mass spectra files obtained from mass spectrometry analysis
were searched using Mascot 2.4.1 (Matrix Science, London,
UK) and 2 databases each containing the RAST [80] pre-
dicted coding sequences (CDS) of one Bifidobacterium
strain, i.e., 2,077 CDS for B. kashiwanohense PV20–2 and
1704 CDS for B. pseudolongum PV8–2. Mascot search pa-
rameters were tryptic peptides with a maximum of one
missed cleavage during proteolytic digestion, mass toler-
ances of 7 ppm on the parent ion and 0.7 Da on the MS/
MS. Oxidation of methionine (M) and pyroglutamate for-
mation from N-terminal glutamine (N-term Q) were set as
variable modifications. Scaffold 4.3 from Proteome Software
was used to validate MS/MS based peptide and protein
identifications using Mascot and X!Tandem cyclone
2010.12.01.1. Protein probabilities were assigned by the
Protein Prophet algorithm [81]. Peptide and protein identi-
fications were accepted when less than 1% False Discovery
Rate was achieved. The function MudPit was used to group
the eight fractions in each of the three biological replicates.
Finally, a protein was considered valid when it was identi-
fied in all three biological replicates, at least two different
peptides were detected, a signal peptide with one of the two
predictors was found and/or reported to be extracellular.
Additional files
Additional file 1: “PVazquez_etal_additional_file_1”. The file contains
the following 2 tables: Table S1a. Complete sequenced genomes of
bifidobacteria used in this study and their Genbank accession numbers
(sheet 1) and Table S1b. Contigs of partially sequenced bifidobacteria
used in this study and their Genbank accession numbers (sheet 2).
(XLSX 62 kb)
Additional file 2: “PVazquez_etal_additional_file_2”. The file contains
the following 2 tables: Table S2a. Genes uniquely found in PV20–2 when
compared to all bifidobacteria (sheet 1) and Table S2b. Genes uniquely
found in PV20–2 compared to DSM21854 (sheet 2). (XLSX 35 kb)
Additional file 3: “PVazquez_etal_additional_file_3”. The file contains
the following 2 tables: Table S3a. Genes uniquely found in PV8–2 when
compared to all bifidobacteria (sheet 1) and Table S3b. Genes uniquely
found in PV8–2 compared to AGR 2145 and DSM20092 (sheet 2).
(XLSX 13 kb)
Additional file 4: “PVazquez_etal_additional_file_3”. The file contains
the following tables: Table S4. Proteins identified in the exoproteome of
B. kashiwanohense PV20–2. Table S5. Proteins identified in the
exoproteome of B. pseudolongum PV8–2. (XLSX 23 kb)
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